slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 13,081-13,110
Pages 819
Rows per page 30
Slide function
13,081-13,110 of 24,547
13
The slide showcases three core product features using mobile and web UI screenshots.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The slide highlights the breadth of genetic reporting and emphasizes FDA authorizations.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
17
The slide highlights the value proposition of the premium subscription tier.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
22
Uses a simple equation-style visual to show the merger/partnership of two entities resulting in a set of service offerings.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
24
23andMe | Investor Presentation Deck | 63 slides23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The slide uses a gradient background and visual representations of mobile app screens to illustrate the integration of genetic insights into primary care.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
35
The slide uses a funnel metaphor to show the narrowing of research targets.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
38
The slide uses a three-column process flow to connect market opportunity, genetic validation, and biological mechanism.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
39
The slide uses a biological pathway diagram to explain the mechanism of action for potential combination therapies.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
42
The slide uses a split-screen layout with a gradient background on the left and key bullet points on the right.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
44
Uses heatmaps to visualize genetic associations with various disease phenotypes.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
46
The slide uses a before-after diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
48
23andMe | Investor Presentation Deck | 63 slides23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
61
Uses a 'fill in the blanks' analogy to explain genotype imputation.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
63
The slide uses a numbered list format to outline key strategic pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
25
3M | Investor Day Presentation Deck | 94 slides3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
39
The diagram on the left illustrates a workflow from real/virtual materials through simulation to material selection.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
42
The slide uses a combination of SEM imagery for optical metamaterials and a bulleted list for the broader innovation portfolio.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
10
Uses a simple additive framework to show how three distinct strategies combine to drive growth.Talkspace | Investor Conference Presentation Deck | 14 slides · Talkspace
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a process flow diagram to map technology features to specific stages of the patient care journey.Talkspace | Investor Conference Presentation Deck | 14 slides · Talkspace
Conference presentation Investor relations 1 hit
32
The slide uses a simple additive framework to illustrate the dual-track growth strategy.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
10
The slide emphasizes exclusivity in the development pipeline for both modalities.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
13
The slide uses a central illustration of a microglial cell with radiating labels describing its functions.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
14
Scientific diagram showing receptor activation upon binding to debris.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
17
The slide uses a honeycomb-style layout to present five key product attributes.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
27
Slide 27 of a pitch deck. Contains three distinct chart/image panels showing efficacy of VGL101.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
36
The slide presents a technical specification table for a drug development program.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
37
The chart shows dose-response curves for VG-2862 concentration vs. pSYK activation signal, comparing 'No Fab' (control) against four different Fabs.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
38
The slide shows four dose-response plots. The EC50 values are explicitly labeled for the three active cases.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
50
The slide uses a causal chain diagram to explain the disease progression and a biological process diagram to explain the therapeutic intervention.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit